Showing 8241-8250 of 10256 results for "".
- Win for MC2 Therapeutics: Wynzora Cream Approved for Adults with Psoriasishttps://practicaldermatology.com/news/win-for-mc2-therapeutics-wynzora-cream-approved-for-adults-with-psoriasis/2460476/FDA has approved Wynzora® Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) from MC2 Therapeutics for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older. The approval is based on results of the US Phase 3 clinical trial&nbs
- ISHRS: New Guidelines for Hair Restoration Surgery During COVID-19 Pandemichttps://practicaldermatology.com/news/ishrs-new-guidelines-for-hair-restoration-surgery-during-covid-19-pandemic-1/2460469/Hair restoration surgeries can proceed safely in the midst of the ongoing COVID-19 pandemic, the International Society of Hair Restoration Surgery (ISHRS) says. The organization has established suggested protocols for resuming hair restoration practices and offers patients guidance in f
- Ortho Dermatologics Launches Arazlo Lotion in the UShttps://practicaldermatology.com/news/ortho-dermatologics-launches-arazlo-lotion-in-the-us/2460447/Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics launched Arazlo (tazarotene) Lotion, 0.045%. Now available commercially to health care professionals in the US, it was FDA approved in December 2019 as the first tazaroten
- Cynosure Reopening Survey: If You Wear Masks, They Will Come Backhttps://practicaldermatology.com/news/cynosure-reopening-survey-if-you-wear-masks-they-will-come-back/2460441/Fully 85 percent of people plan to return to aesthetic treatments within 12 months of COVID-19 restrictions being lifted, and 63 percent plan to return to practices within just three months of restrictions being lifted in their respective countries, according to a
- Potential Stem Cell Research Breakthrough: Researchers Grow Hairy Skin from Human Stem Cellshttps://practicaldermatology.com/news/potential-stem-cell-research-breakthrough-researchers-grow-hairy-skin-from-human-stem-cells/2460414/Scientists from Indiana University School of Medicine and Harvard Medical School have determined how to grow hairy skin using human stem cells. Their study, published in Nature, shows that skin generated from p
- Promising Data from Dermavant's Phase 2b Study of Tapinarof in Psoriasishttps://practicaldermatology.com/news/promising-data-from-dermavants-phase-2b-study-of-tapinorof-in-psoriasis/2460405/Patients treated with once daily tapinarof 1% demonstrated improvement in PASI75 as early as week 2, according to data published in The Journal of the American Academy of Dermatology (JAAD) and reported by drug developer Dermavant. Data come from the Phase
- May Is Ichthyosis Awareness Monthhttps://practicaldermatology.com/news/may-is-ichthyosis-awareness-month/2460390/May is Ichthyosis Awareness Month, and Timber Pharmaceuticals, LLC is highlighting the efforts of the
- Done Deal: AbbVie Completes Acquisition of Allerganhttps://practicaldermatology.com/news/done-deal-abbvie-completes-acquisition-of-allergan/2460389/AbbVie completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court. In connection with the closing of the transaction, the AbbVie Board of Directors has elec
- Industry Responds to COVID-19: Allergan Foundation Doubles Down on COVID-19 Donationshttps://practicaldermatology.com/news/industry-responds-allergan-foundation-doubles-down-on-covid-19-donations/2460385/The Allergan Foundation fast-tracked another $2 million dollars in charitable grants for community organizations responding to the COVID-19 pandemic, doubling their COVID-19 donations to date, raising the total to $4 million. The donations are dedicated to 57 organ
- COVID-19 By the Numbers: April 28 Editionhttps://practicaldermatology.com/news/covid-19-by-the-numbers-april-28-edition/2460365/The CDC now lists nine potential symptoms of COVID-19, though cough and shortness of breath or difficulty breathing remain hallmarks of the disease. CDC says individuals may have COVID-19 if they experience these two symptoms plus at least two of the following: Fever